Baillie Gifford & CO Ginkgo Bioworks Holdings, Inc. Transaction History

Baillie Gifford & CO

$126 Billion
Q1 2024

A detailed history of Baillie Gifford & CO transactions in Ginkgo Bioworks Holdings, Inc. stock. As of the latest transaction made, Baillie Gifford & CO holds 232,999,673 shares of DNA stock, worth $76.9 Million. This represents 0.21% of its overall portfolio holdings.

Number of Shares

232,999,673

Previous 236,292,183 1.39%

Holding current value

$76.9 Million

Previous $399 Million 32.32%

% of portfolio

0.21%

Previous 0.32%

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 01, 2024	SELL	$1.06 - $1.67 $3.49 Million - $5.5 Million	-3,292,510 Reduced 1.39%	232,999,673 $270 Million
Q4 2023 Jan 26, 2024	SELL	$1.26 - $1.79 $3.17 Million - $4.5 Million	-2,516,640 Reduced 1.05%	236,292,183 $399 Million
Q3 2023 Nov 13, 2023	SELL	$1.61 - $2.54 $3.66 Million - $5.77 Million	-2,272,582 Reduced 0.94%	238,808,823 $432 Million
Q2 2023 Jul 28, 2023	SELL	$1.14 - $1.95 $2.04 Million - $3.48 Million	-1,786,855 Reduced 0.74%	241,081,405 $448 Million
Q1 2023 May 03, 2023	SELL	$1.2 - $2.19 $1.57 Million - $2.87 Million	-1,308,383 Reduced 0.54%	242,868,260 $323 Million

Q4 2022 Jan 24, 2023	BUY	$1.63 - $3.52 $65.4 Million - $141 Million	40,099,800 Added 19.65%	244,176,643 $413 Million
Q3 2022 Oct 27, 2022	SELL	$0.73 - $3.74 $913,188 - $4.68 Million	-1,250,943 Reduced 0.61%	204,076,843 $637 Million
Q2 2022 Aug 08, 2022	BUY	$2.2 - $4.2 $82.7 Million - $158 Million	37,575,106 Added 22.4%	205,327,786 $489 Million
Q1 2022 May 05, 2022	BUY	$2.83 - $8.69 $165 Million - $507 Million	58,302,509 Added 53.27%	167,752,680 $676 Million
Q4 2021 Jan 20, 2022	BUY	$8.31 - $14.92 $153 Million - $275 Million	18,447,361 Added 20.27%	109,450,171 $910 Million
Q3 2021 Oct 19, 2021	BUY	$9.15 - $13.28 $833 Million - $1.21 Billion	91,002,810 New	91,002,810 $1.05 Billion

Others Institutions Holding DNA

# of Institutions

360

Shares Held

1.26B

Call Options Held

845K

Put Options Held

2.54M

View Full List

About Ginkgo Bioworks Holdings, Inc.

Ticker DNA
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 1,287,779,968
Market Cap $425M
Description
Ginkgo Bioworks Holdings, Inc., together with its subsidiaries, develops platform for cell programming. Its platform is used to program cells to enable biological production of products, such as novel therapeutics, food ingredients, and chemicals derived from petroleum. The company serves various end markets, including specialty chemicals, agric...

More about DNA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Baillie Gifford & CO, based on Form 13F filings with the SEC.

News

Stay updated on Baillie Gifford & CO with notifications on news.

Account

Baillie Gifford & CO Ginkgo Bioworks Holdings, Inc. Transaction History